Compounds that are able to reduce excessive levels of ROS, Aβ production, oligomerization, neurotoxicity and inflammation induced by Aβ and inhibit tau protein hyperphosphorylation are potential targets for the discovery of new drugs with anti-AD properties [1,2,6,12,18]. The gene discussed is MAPT; the disease is Alzheimer disease.